NFL Biosciences Reveals New Study Insights on NFL-101 for Tobacco Addiction

NFL Biosciences, in collaboration with the CEA, announced deeper insights into NFL-101's effects through a recent study. This biopharmaceutical company focuses on developing botanical medicines for addiction treatment. The study confirmed NFL-101’s prolonged activity by identifying targeted brain regions involved in tobacco withdrawal. This differs from conventional treatments which require continuous doses for efficacy.

Administered in two doses, NFL-101 demonstrates efficacy over placebo, particularly influencing brain areas like the cortex and thalamus. These regions are central to quitting challenges. The new findings enhance discussions for strategic partnerships. The prolonged effect, observed over 16 days in mice, highlights NFL-101's potential for sustained withdrawal symptom relief.